Výsledky vyhledávání - "SHOGO KUWAHARA"

In Vitro Pharmacokinetic and Pharmacodynamic Evaluation of S-013420 against Haemophilus influenzae and Streptococcus pneumoniae

Autor: Shogo Kuwahara, Tomoyuki Homma, Merime Ohshiro, Yoshinori Yamano, Hideki Maki, Jingoro Shimada, Toshihiko Hori

Publikováno v: Antimicrobial Agents and Chemotherapy. 54:4300-4305

The pharmacokinetic (PK)/pharmacodynamic (PD) parameters and the antibacterial activity of S-013420, a novel bicyclolide, against Haemophilus influenzae and Streptococcus pneumoniae , including macrolide-resistant isolates, were investigated using an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6f6af1e40363fd1818f2e9a3f75eac1
https://doi.org/10.1128/aac.00214-10

Zobrazit plný text záznamu

In Vivo Antibacterial Activity of S-3578, a New Broad-Spectrum Cephalosporin: Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Experimental Infection Models

Autor: Hideaki Miwa, Shogo Kuwahara, Masakatsu Tsuji, Jingoro Shimada, Morio Takema

Publikováno v: Antimicrobial Agents and Chemotherapy. 47:2507-2512

The in vivo antibacterial activity of S-3578, a new parental cephalosporin, was compared with those of cefepime, ceftriaxone, ceftazidime, imipenem-cilastatin, and vancomycin. The efficacy of S-3578 against systemic infections caused by methicillin-r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ca1799b432652a8df9fb394c60793e
https://doi.org/10.1128/aac.47.8.2507-2512.2003

Zobrazit plný text záznamu

In Vitro Activity of S-3578, a New Broad-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococci

Autor: Takaji Fujimura, Isamu Yoshida, Shogo Kuwahara, Yoshinori Yamano, Jingoro Shimada

Publikováno v: Antimicrobial Agents and Chemotherapy. 47:923-931

The in vitro antibacterial activity of S-3578, a new parenteral cephalosporin, against clinical isolates was evaluated. The MICs of the drug at which 90% of the isolates were inhibited were 4 μg/ml for methicillin-resistant Staphylococcus aureus (MR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1fcd4cb47abb2a6402410da7eeadcb2
https://doi.org/10.1128/aac.47.3.923-931.2003

Zobrazit plný text záznamu

Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Disseminated Candidiasis and Aspergillosis

Autor: Shogo Kuwahara, Toshio Goto, Satoru Matsumoto, Yuji Watanabe, Katsuyuki Maki, Etsuko Watabe, Fumio Matsumoto, Shuichi Tawara, Fumiaki Ikeda, Yoshimi Wakai

Publikováno v: Antimicrobial Agents and Chemotherapy. 44:614-618

The efficacy of intravenous injection of FK463, a novel water-soluble lipopeptide, was evaluated in mouse models of disseminated candidiasis and aspergillosis and was compared with those of fluconazole (FLCZ) and amphotericin B (AMPH-B). In the candi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21fc411bdc701a154be3c19ffbb3ba75
https://doi.org/10.1128/aac.44.3.614-618.2000

Zobrazit plný text záznamu

In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi

Autor: Kazumi Otomo, Noriko Teratani, Katsuyuki Maki, Akira Yamada, Hidenori Ohki, Hisashi Takasugi, Yoshihiko Morishita, Masaki Tomishima, Hirokazu Tanaka, Fumiaki Ikeda, Koji Kawabata, Fumio Matsumoto, Shogo Kuwahara, Toshio Goto, Shuichi Tawara, Kazuo Sakane

Publikováno v: Antimicrobial Agents and Chemotherapy. 44:57-62

The currently available antifungal drugs for the treatment of deep-seated mycoses are limited to amphotericin B (AMPH-B), azole compounds, and flucytosine. AMPH-B remains the drug of choice for the treatment of most fungal diseases because it has bro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fffc6c1174759bac2ad17086f254441
https://doi.org/10.1128/aac.44.1.57-62.2000

Zobrazit plný text záznamu

Efficacy of CS-834 against Experimental Pneumonia Caused by Penicillin-Susceptible and -Resistant Streptococcus pneumoniae in Mice

Autor: Tamako Harasaki, Takashi Fukuoka, Shogo Kuwahara, Satoshi Ohya, Mikie Kubota, Akiko Kitayama, Tetsufumi Koga, Yasuki Kamai, Harumi Kawada, Masayuki Iwata, Hiroshi Yasuda

Publikováno v: Antimicrobial Agents and Chemotherapy. 42:23-27

The efficacy of CS-834, a novel oral carbapenem, was assessed by using a murine model of pneumonia caused by penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae and was compared with those of oral cephems, i.e., cefteram pivoxil,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00c77d880a7baad0a2490fc8566720d4
https://doi.org/10.1128/aac.42.1.23

Zobrazit plný text záznamu

In Vitro Antibacterial Activity of a New Oral Cephalosporin, S-1090

Autor: Isao Higashiyama, Shimaru Sasaki, Masayoshi Doi, Kiyoshi Motokawa, Tadashi Yoshida, Hiroshi Nagata, Shogo Kuwahara, Yoshihide Komatsu, Kazuhisa Murakami

Publikováno v: Journal of Infection and Chemotherapy. 3:38-48

A new oral cephem antibiotic S-1090 was evaluated for its in vitro antibacterial activity in comparison with cefdinir, cefpodoxime, and cefaclor. S-1090 had fairly potent antibacterial activity when compared with cefdinir, cefpodoxime, and cefaclor.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::49e42d4426bac2e7f6e502e2033341e1
https://doi.org/10.1007/bf02489183

Zobrazit plný text záznamu

In vivo antibacterial activity of FK307, a novel parenteral broad-spectrum cephalosporin

Autor: YASUHIRO MINE, YUJI WATANABE, HIROSHI SAKAMOTO, KAZUO HATANO, YOSHIMI WAKAI, TOSHIAKI KAMIMURA, SHUICHI TAWARA, SATORU MATSUMOTO, FUMIO MATSUMOTO, SHOGO KUWAHARA

Publikováno v: The Journal of Antibiotics. 46:88-98

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3797616ed53492ccc7ffea54db5a6473
https://doi.org/10.7164/antibiotics.46.88

Zobrazit plný text záznamu

In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin

Autor: YASUHIRO MINE, YUJI WATANABE, HIROSHI SAKAMOTO, KAZUO HATANO, KYOICHIRO KUNO, YASUYUKI HIGASHI, TOSHIAKI KAMIMURA, YOSHIMI MATSUMOTO, SHUICHI TAWARA, FUMIO MATSUMOTO, SHOGO KUWAHARA

Publikováno v: The Journal of Antibiotics. 46:71-87

FK037 is a new parenteral cephalosporin, which offers some advantages over the commercially available parenteral cephalosporins. It demonstrated potent broad-spectrum activity against clinical isolates of Gram-positive bacteria including methicillin-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf65321e0219e2a4fe1abe6843598cb0
https://doi.org/10.7164/antibiotics.46.71

Zobrazit plný text záznamu

In vitro antibacterial activities of S-013420, a novel bicyclolide, against respiratory tract pathogens

Autor: Shogo Kuwahara, Hideki Maki, Takaji Fujimura, Yoshinori Yamano, Jingoro Shimada, Tomoyuki Homma

Publikováno v: The Journal of antimicrobial chemotherapy. 65(7)

The in vitro activity of S-013420, a novel bicyclolide, was investigated.All test strains for this study were isolated from Japanese medical facilities. MICs were determined by the microbroth dilution method or agar dilution method according to the C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515c0a6ffdfa08b89730cd4ab598e8d0
https://pubmed.ncbi.nlm.nih.gov/20472695

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání